The results of our randomized controlled clinical trial are excellent news for people with metastatic breast cancer. It shows that they can experience a significantly better quality of life with significantly less fatigue; they can also have less pain and other disease symptoms and treatment side-effects if they take part in a supervised exercise programme as part of their treatment.

To share these results, our partners at Europa Donna have now created a brochure. In this brochure you can find out more about the PREFERABLE Project and what the results mean for people with MBC.

We are delighted to announce the presentation of final results of the PREFERABLE project during a workshop, at the MASCC congress in Lille on June 29th 2024! 

PREFERABLE-EFFECT is the first large international RCT investigating the effect of supervised exercise in patients with metastatic breast cancer. The consortium also investigated the different perspectives of patients on exercise after a diagnosis of metastatic breast cancer using a mixed method design (i.e., focus groups and questionnaires), the PREFERABLE-PERSPECTIVE study. The ultimate goal of the PREFERABLE project is to deliver a strategy that enables implementation of exercise interventions into clinical guidelines. 

During the final symposium, beneficial effects of the exercise intervention on the primary outcomes, fatigue and quality life, will be presented as well as effects on other outcomes. Additionally, a study participant will share her experiences and tell how exercise changed her life. We will also delve into the key findings regarding patient perspectives. Renowned guest speakers, like Kathryn Schmidt, Nicolas Hart, and Anna Campbell, will present their view on the outcomes of Preferable-EFFECT. The workshop will conclude with a panel discussion on implementation of exercise for patients with metastatic breast cancer in the European Healthcare system. 

Is a 9-month exercise program for patients with metastatic breast cancer likely to be cost-effective? Yes!

At the American Society of Clinical Oncology (ASCO) annual meeting in Chicago we presented results of the PREFERABLE-EFFECT study. The results show that exercise effectively reduces side effects of patients with metastatic breast cancer and reduces healthcare and societal costs!